(NEU) NewMarket - Overview
Stock: Lubricant Additives, Fuel Additives, Antiknock Compounds, Contract Manufacturing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.69% |
| Yield on Cost 5y | 3.19% |
| Yield CAGR 5y | 8.90% |
| Payout Consistency | 73.8% |
| Payout Ratio | 42.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.6% |
| Relative Tail Risk | -5.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 35.69 |
| Character TTM | |
|---|---|
| Beta | 0.480 |
| Beta Downside | 0.237 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.90% |
| CAGR/Max DD | 1.14 |
Description: NEU NewMarket January 08, 2026
NewMarket Corporation (NYSE: NEU) manufactures and sells a broad portfolio of petroleum-based additives, covering lubricant formulations for engines, transmissions, hydraulics, turbines and specialty industrial applications, as well as fuel-enhancing compounds for gasoline, diesel, biofuels and refining processes. The business serves a global customer base-including OEMs, governments and end-users-across North America, Latin America, APAC, Europe, the Middle East, Africa and India, and also provides contracted manufacturing and real-estate services.
Key operating metrics from the most recent 10-K (FY 2023) show total revenue of roughly **$1.5 billion** with an adjusted EBITDA margin near **10 %**, reflecting the capital-intensive nature of specialty chemicals. The segment most sensitive to macro trends is fuel additives, which benefit from tighter global emissions standards and the ongoing shift toward higher-octane, low-sulfur fuels-a driver that has historically delivered a **3-5 % CAGR** in additive volumes. Conversely, the lubricant-additive line faces a modest headwind from the gradual electrification of transportation, although off-road and industrial equipment still demand robust additive solutions.
For a deeper, data-driven look at NEU’s valuation and risk profile, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 448.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.64 > 1.0 |
| NWC/Revenue: 25.17% < 20% (prev 26.51%; Δ -1.34% < -1%) |
| CFO/TA 0.19 > 3% & CFO 609.0m > Net Income 448.2m |
| Net Debt (759.5m) to EBITDA (745.2m): 1.02 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.40m) vs 12m ago -2.08% < -2% |
| Gross Margin: 31.86% > 18% (prev 0.31%; Δ 3155 % > 0.5%) |
| Asset Turnover: 85.76% > 50% (prev 87.65%; Δ -1.89% > 0%) |
| Interest Coverage Ratio: 15.03 > 6 (EBITDA TTM 745.2m / Interest Expense TTM 41.5m) |
Altman Z'' 5.49
| A: 0.21 (Total Current Assets 1.10b - Total Current Liabilities 410.5m) / Total Assets 3.23b |
| B: 0.50 (Retained Earnings 1.62b / Total Assets 3.23b) |
| C: 0.19 (EBIT TTM 623.1m / Avg Total Assets 3.20b) |
| D: 1.09 (Book Value of Equity 1.69b / Total Liabilities 1.54b) |
| Altman-Z'' Score: 5.49 = AAA |
Beneish M -3.15
| DSRI: 0.91 (Receivables 438.8m/487.6m, Revenue 2.74b/2.78b) |
| GMI: 0.97 (GM 31.86% / 30.84%) |
| AQI: 1.07 (AQ_t 0.41 / AQ_t-1 0.38) |
| SGI: 0.99 (Revenue 2.74b / 2.78b) |
| TATA: -0.05 (NI 448.2m - CFO 609.0m) / TA 3.23b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of NEU shares?
Over the past week, the price has changed by +7.92%, over one month by +1.16%, over three months by -4.84% and over the past year by +41.30%.
Is NEU a buy, sell or hold?
What are the forecasts/targets for the NEU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 450 | -37.8% |
| Analysts Target Price | 450 | -37.8% |
| ValueRay Target Price | 896.8 | 23.9% |
NEU Fundamental Data Overview February 04, 2026
P/S = 2.3243
P/B = 3.729
P/EG = 5.09
Revenue TTM = 2.74b USD
EBIT TTM = 623.1m USD
EBITDA TTM = 745.2m USD
Long Term Debt = 783.1m USD (from longTermDebt, last quarter)
Short Term Debt = 16.9m USD (from shortTermDebt, last quarter)
Debt = 861.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 759.5m USD (from netDebt column, last quarter)
Enterprise Value = 7.14b USD (6.38b + Debt 861.9m - CCE 102.5m)
Interest Coverage Ratio = 15.03 (Ebit TTM 623.1m / Interest Expense TTM 41.5m)
EV/FCF = 13.10x (Enterprise Value 7.14b / FCF TTM 544.8m)
FCF Yield = 7.63% (FCF TTM 544.8m / Enterprise Value 7.14b)
FCF Margin = 19.85% (FCF TTM 544.8m / Revenue TTM 2.74b)
Net Margin = 16.33% (Net Income TTM 448.2m / Revenue TTM 2.74b)
Gross Margin = 31.86% ((Revenue TTM 2.74b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 30.37% (prev 31.63%)
Tobins Q-Ratio = 2.21 (Enterprise Value 7.14b / Total Assets 3.23b)
Interest Expense / Debt = 0.97% (Interest Expense 8.37m / Debt 861.9m)
Taxrate = 26.06% (35.3m / 135.6m)
NOPAT = 460.7m (EBIT 623.1m * (1 - 26.06%))
Current Ratio = 2.68 (Total Current Assets 1.10b / Total Current Liabilities 410.5m)
Debt / Equity = 0.51 (Debt 861.9m / totalStockholderEquity, last quarter 1.69b)
Debt / EBITDA = 1.02 (Net Debt 759.5m / EBITDA 745.2m)
Debt / FCF = 1.39 (Net Debt 759.5m / FCF TTM 544.8m)
Total Stockholder Equity = 1.57b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.01% (Net Income 448.2m / Total Assets 3.23b)
RoE = 28.53% (Net Income TTM 448.2m / Total Stockholder Equity 1.57b)
RoCE = 26.47% (EBIT 623.1m / Capital Employed (Equity 1.57b + L.T.Debt 783.1m))
RoIC = 18.67% (NOPAT 460.7m / Invested Capital 2.47b)
WACC = 6.85% (E(6.38b)/V(7.24b) * Re(7.68%) + D(861.9m)/V(7.24b) * Rd(0.97%) * (1-Tc(0.26)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.05%
[DCF Debug] Terminal Value 83.80% ; FCFF base≈506.8m ; Y1≈568.2m ; Y5≈756.3m
Fair Price DCF = 1715 (EV 16.87b - Net Debt 759.5m = Equity 16.12b / Shares 9.40m; r=6.85% [WACC]; 5y FCF grow 14.06% → 2.90% )
EPS Correlation: -28.36 | EPS CAGR: -39.60% | SUE: 0.0 | # QB: 0
Revenue Correlation: 37.42 | Revenue CAGR: 4.92% | SUE: N/A | # QB: 0